Magyarlaki T - Search Results

1

Simultaneous presence of neutrophil alveolitis and Ki-67 positivity of alveolar macrophages in dermato-/polymyositis and systemic sclerosis.

Kumánovics G, Magyarlaki T, Komócsi A, Szekeres G, Czirják L. Kumánovics G, et al. Among authors: magyarlaki t. Rheumatol Int. 2003 Jan;23(1):6-10. doi: 10.1007/s00296-002-0243-6. Epub 2002 Sep 11. Rheumatol Int. 2003. PMID: 12548435

2

Comparison of conventional aggregometry with VASP for monitoring P2Y12-specific platelet inhibition.

Aradi D, Magyarlaki T, Tokés-Füzesi M, Rideg O, Vorobcsuk A, Komócsi A. Aradi D, et al. Among authors: magyarlaki t. Platelets. 2010;21(7):563-70. doi: 10.3109/09537104.2010.494742. Platelets. 2010. PMID: 20642320

3

Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention.

Rideg O, Komócsi A, Magyarlaki T, Tokés-Füzesi M, Miseta A, Kovács GL, Aradi D. Rideg O, et al. Among authors: magyarlaki t. Pharmacogenomics. 2011 Sep;12(9):1269-80. doi: 10.2217/pgs.11.73. Epub 2011 Aug 1. Pharmacogenomics. 2011. PMID: 21806387 Clinical Trial.

4

Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity.

Aradi D, Rideg O, Vorobcsuk A, Magyarlaki T, Magyari B, Kónyi A, Pintér T, Horváth IG, Komócsi A. Aradi D, et al. Among authors: magyarlaki t. Eur J Clin Invest. 2012 Apr;42(4):384-92. doi: 10.1111/j.1365-2362.2011.02594.x. Epub 2011 Sep 9. Eur J Clin Invest. 2012. PMID: 21902692 Clinical Trial.

5

Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis.

Aradi D, Komócsi A, Vorobcsuk A, Rideg O, Tokés-Füzesi M, Magyarlaki T, Horváth IG, Serebruany VL. Aradi D, et al. Among authors: magyarlaki t. Am Heart J. 2010 Sep;160(3):543-51. doi: 10.1016/j.ahj.2010.06.004. Am Heart J. 2010. PMID: 20826265 Review.

6

Bilateral congenital segmental megaureter.

Pintér AB, Szabo L, Szever ZS, Magyarlaki T. Pintér AB, et al. Among authors: magyarlaki t. J Urol. 1997 Aug;158(2):570-1. J Urol. 1997. PMID: 9224363 No abstract available.

7

Immunohistochemistry of complement response on human renal cell carcinoma biopsies.

Magyarlaki T, Mosolits S, Baranyay F, Buzogány I. Magyarlaki T, et al. Tumori. 1996 Sep-Oct;82(5):473-9. doi: 10.1177/030089169608200513. Tumori. 1996. PMID: 9063527

8

Comparison of some lymphocyte markers in B-cell chronic lymphocytic leukaemia and systemic lupus erythematosus (the B lymphocyte subset).

Magyarlaki T, Losonczy H, Pár A. Magyarlaki T, et al. Haematologia (Budap). 1990;23(2):111-20. Haematologia (Budap). 1990. PMID: 2148733

9

Renal angiomyolipoma: report of three cases with regional lymph node involvement and/or with renal cell carcinoma.

Csanaky G, Szereday Z, Magyarlaki T, Méhes G, Herbert T, Buzogány I. Csanaky G, et al. Among authors: magyarlaki t. Tumori. 1995 Nov-Dec;81(6):469-74. doi: 10.1177/030089169508100619. Tumori. 1995. PMID: 8804480

10

Activated platelet-derived microparticle numbers are elevated in patients with severe fungal (Candida albicans) sepsis.

Woth G, Tőkés-Füzesi M, Magyarlaki T, Kovács GL, Vermes I, Mühl D. Woth G, et al. Among authors: magyarlaki t. Ann Clin Biochem. 2012 Nov;49(Pt 6):554-60. doi: 10.1258/acb.2012.011215. Epub 2012 Aug 29. Ann Clin Biochem. 2012. PMID: 22933445

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters